• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>First Data

First Data

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. J.P. Morgan CEO James Dimon Diagnosed With Throat Cancer -- Update

    J.P. Morgan CEO James Dimon Diagnosed With Throat Cancer -- Update

  2. J.P. Morgan CEO James Dimon Diagnosed With Throat Cancer -- Update

    J.P. Morgan CEO James Dimon Diagnosed With Throat Cancer -- Update

  3. J.P. Morgan CEO Diagnosed With Throat Cancer

    J.P. Morgan CEO Diagnosed With Throat Cancer

  4. Research and Markets: Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS 2014

    Research and Markets: Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS 2014

  5. Salesforce.com Increases Investment in France to Power Digital Transformation of French Companies

    Salesforce.com Increases Investment in France to Power Digital Transformation of French Companies

  6. Some Steam for Global Growth in 2014

    Waning austerity measures and more trade will help, but tight lending and moderating growth in China may be headwinds.

  7. Fund Times: Pioneer Loses Star High-Yield Manager

    Plus, First Data buyout boosts funds, manager changes at Fidelity, and more.

  8. Stocks Attractive on a Relative, But Not Absolute, Basis

    Investors should keep their expectations in check with few asset classes looking particularly attractive and complacency in the marketplace, says Allocation Fund Manager of the Year David Giroux of T. Rowe Price Capital Appreciation.

  9. Small Companies Mean the World to Him

    Wasatch veteran Robert Gardiner starts a new firm but bringsĀ along his successful micro- and small-cap investing approach.

  10. Market Mood Gyrations Continue on an Hourly Basis

    Even amid market mood swings courtesy of the Fed, steadily rising employment offset weak manufacturing data.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.